Equities

Selcuk Ecza Deposu Ticaret ve Sanayi AS

SELEC.E:IST

Selcuk Ecza Deposu Ticaret ve Sanayi AS

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TRY)48.76
  • Today's Change1.14 / 2.39%
  • Shares traded988.74k
  • 1 Year change+45.47%
  • Beta0.7531
Data delayed at least 15 minutes, as of May 31 2024 16:08 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Selcuk Ecza Deposu Ticaret ve Sanayi AS (Selcuk Ecza) is a Turkey-based medical warehousing company that serves as the distribution channel between pharmaceutical companies, pharmacies and hospitals. The Company distributes pharmaceutical products, as well as cosmetics, personal care, infant food, vitamins, medical and similar products. The Company operates through a network of five branches located in Ankara, Samsun, Izmir, Konya and Antalya. As of December 31, 2011, the Company’s subsidiaries included As Ecza Deposu Ticaret AS, which is engaged in operating as a pharmacy depot through four branches located in Ankara, Kayseri, Izmir and Konya, and Selcuk Ecza Deposu Dis Tic AS, which is active in the export and import of a range of drugs and patent medicines, medical supplies together with pharmacy depot operations.

  • Revenue in TRY (TTM)97.72bn
  • Net income in TRY223.21m
  • Incorporated1970
  • Employees6.03k
  • Location
    Selcuk Ecza Deposu Ticaret ve Sanayi ASAltunizade Mah. Kusbakisi Cad. No:37Altunizade NakkastepeISTANBUL 34662TurkeyTUR
  • Phone+90 2 165540554
  • Fax+90 2 165540556
  • Websitehttps://selcukecza.com.tr/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shanghai New World Co Ltd5.10bn149.53m17.36bn1.20k116.140.9279--3.410.05190.05191.776.500.20264.627.42951,798.100.58580.52420.780.724938.5633.702.892.711.52--0.122282.7533.39-16.40160.85-35.0053.61-25.42
YSB Inc75.64bn-14.21bn20.82bn6.31k--2.43--0.2753-25.65-25.6547.523.24------2,909,354.00--------10.26---18.89--1.01--0.1002--18.90---114.23------
Nu Skin Enterprises, Inc.61.41bn-106.82m21.37bn3.70k--0.81899.600.3481-0.0758-0.075837.8016.301.071.9029.99514,858.10-0.18586.80-0.22988.9068.4273.45-0.1745.261.247.940.373662.58-11.53-5.97-91.80-41.16-3.631.33
Uniphar PLC89.23bn1.57bn24.91bn3.26k15.902.148.850.27910.16410.16419.351.222.1312.6412.71782,667.703.764.126.497.2415.2813.611.771.870.56343.220.533810.9323.3012.48-1.6938.9845.53--
NanJing Pharmaceutical Co Ltd237.96bn2.62bn27.64bn4.90k10.500.9319--0.11620.45130.451341.075.091.638.333.3310,903,610.002.222.327.448.946.046.411.361.301.132.910.635929.826.7111.35-3.0016.93-12.679.86
Selcuk Ecza Deposu Ticaret ve Sanayi AS97.72bn223.21m30.28bn6.03k135.662.0147.270.30990.35940.3594157.3624.252.3010.7310.4216,218,930.000.52553.161.418.409.389.370.22841.241.05--0.138227.1614.7048.64-64.89-10.6223.1320.11
Neuca SA97.98bn1.27bn32.99bn5.19k26.633.7714.240.336734.2534.252,647.46241.932.377.477.172,307,345.003.303.5812.2713.3111.1910.331.391.430.50344.220.303234.595.178.796.588.95-3.07--
Herbalife Ltd163.58bn4.42bn33.19bn9.20k7.51--4.080.20291.371.3750.57-10.391.902.2558.67551,586.905.1411.308.6818.7076.8078.432.706.020.76672.981.760.00-2.730.688-55.74-13.679.95--
DocMorris AG34.64bn-4.20bn34.65bn1.45k--1.84--1.00-10.077.0383.0536.600.986311.3610.50667,214.10-11.96-12.92-15.23-15.7420.9816.84-12.13-10.871.34-2.390.4448--4.13-4.2931.29---2.53--
Guangxi LiuYao Group Co Ltd94.60bn3.96bn38.77bn5.58k8.881.14--0.40992.462.4658.8219.121.076.991.973,807,204.004.805.0611.7312.2111.5611.854.474.401.305.260.543429.909.2312.1821.119.97-8.636.26
Data as of May 31 2024. Currency figures normalised to Selcuk Ecza Deposu Ticaret ve Sanayi AS's reporting currency: Turkish Lira TRY

Institutional shareholders

2.17%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Apr 20244.02m0.65%
Norges Bank Investment Managementas of 31 Dec 20233.00m0.48%
MFS International Singapore Pte Ltd.as of 30 Apr 20242.61m0.42%
Dimensional Fund Advisors LPas of 09 May 20241.47m0.24%
MFS International (UK) Ltd.as of 30 Apr 2024938.96k0.15%
SSgA Funds Management, Inc.as of 09 May 2024339.26k0.06%
Massachusetts Financial Services Co.as of 30 Apr 2024301.11k0.05%
BlackRock Fund Advisorsas of 09 May 2024289.24k0.05%
State Street Global Advisors Ltd.as of 09 May 2024281.70k0.05%
Parametric Portfolio Associates LLCas of 31 Mar 2024240.30k0.04%
More ▼
Data from 31 Dec 2023 - 30 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.